These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

675 related articles for article (PubMed ID: 11518967)

  • 1. Delineation of prognostic biomarkers in prostate cancer.
    Dhanasekaran SM; Barrette TR; Ghosh D; Shah R; Varambally S; Kurachi K; Pienta KJ; Rubin MA; Chinnaiyan AM
    Nature; 2001 Aug; 412(6849):822-6. PubMed ID: 11518967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepsin and maspin are inversely expressed in laser capture microdissectioned prostate cancer.
    Chen Z; Fan Z; McNeal JE; Nolley R; Caldwell MC; Mahadevappa M; Zhang Z; Warrington JA; Stamey TA
    J Urol; 2003 Apr; 169(4):1316-9. PubMed ID: 12629351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human prostate cancer and benign prostatic hyperplasia: molecular dissection by gene expression profiling.
    Luo J; Duggan DJ; Chen Y; Sauvageot J; Ewing CM; Bittner ML; Trent JM; Isaacs WB
    Cancer Res; 2001 Jun; 61(12):4683-8. PubMed ID: 11406537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of PIM-1 is a potential biomarker in prostate carcinoma.
    Xu Y; Zhang T; Tang H; Zhang S; Liu M; Ren D; Niu Y
    J Surg Oncol; 2005 Dec; 92(4):326-30. PubMed ID: 16299799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression profiling reveals hepsin overexpression in prostate cancer.
    Magee JA; Araki T; Patil S; Ehrig T; True L; Humphrey PA; Catalona WJ; Watson MA; Milbrandt J
    Cancer Res; 2001 Aug; 61(15):5692-6. PubMed ID: 11479199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
    Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
    Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pim-1 expression in prostatic intraepithelial neoplasia and human prostate cancer.
    Valdman A; Fang X; Pang ST; Ekman P; Egevad L
    Prostate; 2004 Sep; 60(4):367-71. PubMed ID: 15264249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polo-like kinase 1 is overexpressed in prostate cancer and linked to higher tumor grades.
    Weichert W; Schmidt M; Gekeler V; Denkert C; Stephan C; Jung K; Loening S; Dietel M; Kristiansen G
    Prostate; 2004 Aug; 60(3):240-5. PubMed ID: 15176053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene expression profiling reveals overexpression of TSPAN13 in prostate cancer.
    Arencibia JM; Martín S; Pérez-Rodríguez FJ; Bonnin A
    Int J Oncol; 2009 Feb; 34(2):457-63. PubMed ID: 19148481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression profiling of microdissected matched prostate cancer samples reveals CD166/MEMD and CD24 as new prognostic markers for patient survival.
    Kristiansen G; Pilarsky C; Wissmann C; Kaiser S; Bruemmendorf T; Roepcke S; Dahl E; Hinzmann B; Specht T; Pervan J; Stephan C; Loening S; Dietel M; Rosenthal A
    J Pathol; 2005 Feb; 205(3):359-76. PubMed ID: 15532095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High levels of phosphorylated form of Akt-1 in prostate cancer and non-neoplastic prostate tissues are strong predictors of biochemical recurrence.
    Ayala G; Thompson T; Yang G; Frolov A; Li R; Scardino P; Ohori M; Wheeler T; Harper W
    Clin Cancer Res; 2004 Oct; 10(19):6572-8. PubMed ID: 15475446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth and survival mechanisms associated with perineural invasion in prostate cancer.
    Ayala GE; Dai H; Ittmann M; Li R; Powell M; Frolov A; Wheeler TM; Thompson TC; Rowley D
    Cancer Res; 2004 Sep; 64(17):6082-90. PubMed ID: 15342391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pim-2 upregulation: biological implications associated with disease progression and perinueral invasion in prostate cancer.
    Dai H; Li R; Wheeler T; Diaz de Vivar A; Frolov A; Tahir S; Agoulnik I; Thompson T; Rowley D; Ayala G
    Prostate; 2005 Nov; 65(3):276-86. PubMed ID: 16015593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prohibitin identified by proteomic analysis of prostate biopsies distinguishes hyperplasia and cancer.
    Ummanni R; Junker H; Zimmermann U; Venz S; Teller S; Giebel J; Scharf C; Woenckhaus C; Dombrowski F; Walther R
    Cancer Lett; 2008 Aug; 266(2):171-85. PubMed ID: 18384941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Placental S100 (S100P) and GATA3: markers for transitional epithelium and urothelial carcinoma discovered by complementary DNA microarray.
    Higgins JP; Kaygusuz G; Wang L; Montgomery K; Mason V; Zhu SX; Marinelli RJ; Presti JC; van de Rijn M; Brooks JD
    Am J Surg Pathol; 2007 May; 31(5):673-80. PubMed ID: 17460449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epithelial-restricted gene profile of primary cultures from human prostate tumors: a molecular approach to predict clinical behavior of prostate cancer.
    Nanni S; Priolo C; Grasselli A; D'Eletto M; Merola R; Moretti F; Gallucci M; De Carli P; Sentinelli S; Cianciulli AM; Mottolese M; Carlini P; Arcelli D; Helmer-Citterich M; Gaetano C; Loda M; Pontecorvi A; Bacchetti S; Sacchi A; Farsetti A
    Mol Cancer Res; 2006 Feb; 4(2):79-92. PubMed ID: 16513839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. From gene to clinic: TMA-based clinical validation of molecular markers in prostate cancer.
    Schlomm T; Chun FKh; Erbersdobler A
    Methods Mol Biol; 2010; 664():177-89. PubMed ID: 20690063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of prostate cancer biomarkers by microarray gene expression profiling.
    Sørensen KD; Ørntoft TF
    Expert Rev Mol Diagn; 2010 Jan; 10(1):49-64. PubMed ID: 20014922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The over-expression of Pim-2 promote the tumorigenesis of prostatic carcinoma through phosphorylating eIF4B.
    Ren K; Gou X; Xiao M; Wang M; Liu C; Tang Z; He W
    Prostate; 2013 Sep; 73(13):1462-9. PubMed ID: 23813671
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepsin is highly over expressed in and a new candidate for a prognostic indicator in prostate cancer.
    Stephan C; Yousef GM; Scorilas A; Jung K; Jung M; Kristiansen G; Hauptmann S; Kishi T; Nakamura T; Loening SA; Diamandis EP
    J Urol; 2004 Jan; 171(1):187-91. PubMed ID: 14665873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.